Physician profile
Darrell Freeman
NPI 1700225604
$2,042.28
in general payments reported to CMS, 2019-2025
21 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $350 · 2021: $312 · 2022: $101 · 2023: $414 · 2024: $151 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $576.83 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $420.67 | 2020-2025 | |
| Musculoskeletal Transplant Foundation INC. | $236.16 | 2019-2025 | |
| Kci USA, INC. | $122.97 | 2019 | |
| Sientra, INC. | $101.45 | 2022 | |
| Janssen Biotech, INC. | $88.24 | 2020-2021 | |
| Medimetriks Pharmaceuticals, INC. | $86.76 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $68.17 | 2019-2020 | |
| Dermavant Sciences, INC. | $63.07 | 2023-2024 | Vtama |
| Allergan, INC. | $40.28 | 2019-2021 | |
| Lilly USA, LLC | $34.05 | 2020-2021 | |
| Bracco Diagnostics INC. | $33.70 | 2024 | |
| Organogenesis INC. | $31.55 | 2025 | Novachor |
| Mayne Pharma Commercial LLC | $27.22 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.32 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $18.63 | 2019 | |
| Convatec INC. | $16.37 | 2023 | |
| Verrica Pharmaceuticals INC. | $15.24 | 2023 | Ycanth |
| Tei Biosciences INC | $13.38 | 2019 | |
| Dusa Pharmaceuticals, INC. | $13.10 | 2019 | |
| Galderma Laboratories, L.P. | $11.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.